Saskatchewan Health Research Foundation

2003-2004 Research Group Facilitation Grants

Title

Cancer Proteomics Group

Funding Received

SHRF

39,956

About Program

The Research Group Facilitation Group Program was intended to: encourage and facilitate the formation and development of new groups that consisted of active researchers with common interests who were studying matters associated with the human health sciences, the health-related social sciences or other human health-related fields of study and who were interested in establishing a longer-term association with each other that would benefit their research productivity and competitiveness; advance strategic directions for health research within the home institution or the province; assist in increasing national funding for research in the field of interest in Saskatchewan, especially from the Canadian Institutes of Health Research or another of the Tri-Council agencies; and enhance the capacity for and quality of research in the field of interest and health research generally in Saskatchewan.

John DeCoteau

Pathology

Medicine

University of Saskatchewan

Ronald Geyer

Biochemistry

Medicine

University of Saskatchewan

The Cancer Proteomics Research Group aims to improve patient diagnosis, treatment and survival by refining cancer classifications, by developing new prognostic and predictive markers to guide therapy decisions, and by identifying proteins that may represent novel targets for designing drugs and therapeutic antibodies. Outcomes from the Cancer Proteomics Group studies will provide economic benefits by providing novel protein targets for diagnostic tests and for therapeutic drug and antibody development.

< Back to Search Results

Recipients

John DeCoteau

Ronald Geyer